FindTrial
Sign In

S-1 and cisplatin

DRUG2 trials

Sponsors

Department of Medical Oncology, Toranomon Hospitalnasoi, Asan Medical Center

Conditions

Advanced Gastric CancerStage III (the 14th edition of staging system of Japanese Classification of Gastric Carcinoma) gastric cancer based on pathological findings after curative resection.

Phase 2

A feasibility study of adjuvant S-1+CDDP for stage III gastric cancer
RecruitingJPRN-UMIN000013479
Department of Medical Oncology, Toranomon HospitalnasoiStage III (the 14th edition of staging system of Japanese Classification of Gastric Carcinoma) gastric cancer based on pathological findings after curative resection.
Start: 2014-03-24Target: 30Updated: 2026-06-29

Phase 3

Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
CompletedNCT00915382
Asan Medical CenterAdvanced Gastric Cancer
Start: 2009-01-31End: 2013-05-31Updated: 2020-01-07

Related Papers

Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
2015-07-2740 citations
Phase III trial of a 3-weekly versus 5-weekly schedule of S-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOS study.
Journal of Clinical Oncology2013-06-203 citations